W
WLC

Topic

longevity diagnostics

11 articles on longevity diagnostics in longevity medicine. View all news →

NEJM: Ultrasound Blood-Brain Barrier Opening and Aducanumab in Alzheimer's Disease Peer-reviewed

Focused Ultrasound and the Blood-Brain Barrier: What Alzheimer's Trials Mean for Longevity Clinics

Focused ultrasound can temporarily open the blood-brain barrier in specialist Alzheimer's trials, but it is not routine longevity-clinic brain prevention.

Midjourney Medical: A New Era of Midjourney

Midjourney Medical Scanner: What 60-Second Ultrasonic CT Means for Longevity Clinics

Midjourney Medical's water-based ultrasonic scanner is a serious signal for longevity clinics, but the useful question is not hype. It is who interprets repeat imaging data, what changes in care, and who owns follow-up.

Fountain Life Memberships | CORE, APEX & APEX Family

Fountain Life Alternatives: Cost, Membership, and Clinics to Compare in 2026

Compare Fountain Life alternatives by membership model, diagnostics, follow-up, treatment capacity, price signals, and buyer fit across HLI, Biograph, Progevita, Conradia, YEARS Berlin, and executive-health options.

eBioMedicine: Epigenetic clocks: advancing biological age measures towards meaningful clinical use Peer-reviewed

Epigenetic Testing at Longevity Clinics: Useful Signal or Expensive Noise?

A buyer-focused guide to epigenetic testing at longevity clinics: when biological-age clocks add useful context, when they become sales theater, and what to ask before paying.

FDA: Artificial Intelligence-Enabled Medical Devices Peer-reviewed

AI Diagnostics in Longevity Clinics: Buyer Guide, Red Flags, and Medical Oversight (2026)

A 2026 buyer guide to AI diagnostics in longevity clinics: real use cases, red flags, physician oversight, FDA caveats, and questions before you pay.

Lucent Diagnostics and Tempus integrate blood-based Alzheimer's biomarker testing into clinical workflows

Longevity Tech Radar: FDA-Cleared AI, Biomarkers, and Preventive Diagnostics

This week's radar covers blood-based Alzheimer's biomarkers, FDA-cleared imaging AI, DXA/DEXA upgrades, wearable VO₂ estimates, and smarter questions for buyers.

Nature Aging: OMICmAge quantifies biological age by integrating multi-omics with electronic medical records Peer-reviewed

Biological Age Testing Technologies in 2026: Clocks, Proteomics, Imaging, and What Longevity Clinics Should Actually Measure

A practical 2026 guide to biological age testing in longevity clinics: epigenetic clocks, proteomic and multi-omics clocks, imaging-derived organ age, inflammatory markers, and the clinical tests that actually change decisions.

Lifespan.io: When Doctors Prescribe Horoscopes — The Trouble With Biological Age Tests

Biological Age Tests: Are Longevity Clinics Selling Horoscopes? (2026)

Epigenetic age tests are marketed as the ultimate longevity metric. But the same sample can produce a 15-year discrepancy, there are no clinical standards, and better diagnostics exist. Here's what the science actually says.

PNAS: Clinical findings in a comprehensive, prospective, data-intensive health assessment (2020) Peer-reviewed

Fountain Life vs Human Longevity Inc: The Two Titans of US Longevity Diagnostics (2026)

Fountain Life and Human Longevity Inc. both offer premium diagnostic assessments in the US, but differ on genomic depth, AI integration, pricing model, and geographic reach. A data-driven comparison.

Mayo Clinic Executive Health Program — Overview Peer-reviewed

Mayo Clinic vs Cleveland Clinic Executive Health: Hospital-Grade Longevity Programs Compared (2026)

Mayo Clinic and Cleveland Clinic both offer elite executive health programs with institutional credibility no startup can match. We compare their diagnostics, specialties, pricing, and how they fit into the longevity clinic landscape.